Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

Related Citations for PubMed (Select 23438422)

1.

Kidney stones: an update on current pharmacological management and future directions.

Xu H, Zisman AL, Coe FL, Worcester EM.

Expert Opin Pharmacother. 2013 Mar;14(4):435-47. doi: 10.1517/14656566.2013.775250. Review.

2.

[Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].

Hess B.

Ther Umsch. 2003 Feb;60(2):79-87. German.

PMID:
12649986
3.

Evaluation and medical management of kidney stones in children.

Tasian GE, Copelovitch L.

J Urol. 2014 Nov;192(5):1329-36. doi: 10.1016/j.juro.2014.04.108. Epub 2014 Jun 21. Review.

PMID:
24960469
4.
5.

Metabolic abnormalities associated with calyceal diverticular stones.

Auge BK, Maloney ME, Mathias BJ, Pietrow PK, Preminger GM.

BJU Int. 2006 May;97(5):1053-6.

PMID:
16643491
6.

Pharmacotherapy of kidney stones.

Pak CY.

Expert Opin Pharmacother. 2008 Jun;9(9):1509-18. doi: 10.1517/14656566.9.9.1509 . Review.

PMID:
18518781
7.

Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of Preventive Medical Strategies [Internet].

Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, Brasure M, Kane RL, Monga M.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Jul.

8.

Optimum nutrition for kidney stone disease.

Heilberg IP, Goldfarb DS.

Adv Chronic Kidney Dis. 2013 Mar;20(2):165-74. doi: 10.1053/j.ackd.2012.12.001. Review.

PMID:
23439376
9.

[Randomized trials in the prevention of recurrent calcium oxalate stones].

Presne C, Monge M, Bataille P, el Esper N, Choukroun G, Fournier A.

Nephrologie. 2003;24(6):303-7. Review. French.

PMID:
14584297
10.
11.

Treatment and prevention of kidney stones: an update.

Frassetto L, Kohlstadt I.

Am Fam Physician. 2011 Dec 1;84(11):1234-42. Review.

12.

Medical management of stone disease.

Delvecchio FC, Preminger GM.

Curr Opin Urol. 2003 May;13(3):229-33. Review.

PMID:
12692447
13.

The role of calcium in the prevention of kidney stones.

Heller HJ.

J Am Coll Nutr. 1999 Oct;18(5 Suppl):373S-378S. Review.

PMID:
10511317
14.

Diet and renal stone formation.

Trinchieri A.

Minerva Med. 2013 Feb;104(1):41-54.

PMID:
23392537
15.

Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.

Caudarella R, Vescini F.

Arch Ital Urol Androl. 2009 Sep;81(3):182-7. Review.

PMID:
19911682
16.

Prevention of recurrent nephrolithiasis.

Goldfarb DS, Coe FL.

Am Fam Physician. 1999 Nov 15;60(8):2269-76. Review.

17.

Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.

Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD.

J Urol. 2003 Feb;169(2):465-9.

PMID:
12544288
18.

Use of drugs for nephrolithiasis.

Marangella M, Vitale C, Bagnis C, Petrarulo M, Tricerri A.

Clin Cases Miner Bone Metab. 2008 May;5(2):131-4.

19.

Pharmacological interventions for preventing complications in idiopathic hypercalciuria.

Escribano J, Balaguer A, Pagone F, Feliu A, Roqué I Figuls M.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004754. doi: 10.1002/14651858.CD004754.pub2. Review.

PMID:
19160242
20.

[Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].

Hochreiter W, Knoll T, Hess B.

Ther Umsch. 2003 Feb;60(2):89-97. German.

PMID:
12649987
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk